The goal of HTLV screening in organ donors is to ensure that organs are safe for donation and identification of recipients with HTLV is important, since the transplantation and associated immunosuppressive therapy may play a role in altering immunological control of HTLV infection.
Lazzeri, C., Grossi, P.A., Procissi, A.P.o., Rossolini, G.M., Cusi, M.G., Pane, P.L., et al. (2024). Low seroprevalence of anti‐human T‐cell leukemia virus‐I/II antibodies among brain‐dead donors in Tuscany—An 8‐year observational study. TRANSPLANT INFECTIOUS DISEASE, 26(3) [10.1111/tid.14293].
Low seroprevalence of anti‐human T‐cell leukemia virus‐I/II antibodies among brain‐dead donors in Tuscany—An 8‐year observational study
Cusi, Maria GraziaFormal Analysis
;
2024-01-01
Abstract
The goal of HTLV screening in organ donors is to ensure that organs are safe for donation and identification of recipients with HTLV is important, since the transplantation and associated immunosuppressive therapy may play a role in altering immunological control of HTLV infection.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Transplant Infectious Dis - 2024 - Lazzeri - Low seroprevalence of anti‐human T‐cell leukemia virus‐I II antibodies among.pdf
non disponibili
Descrizione: Letter
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
114.82 kB
Formato
Adobe PDF
|
114.82 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/1279814